These Product Information leaflets apply only in Australia, as the registration details of products may differ in other countries. Product Information is approved by the Therapeutic Goods Administration (TGA), and provides healthcare professionals with a summary of the scientific information relevant to the safe and effective use of the medicine.
If you are not a healthcare professional* please visit For patients and carers to view the Consumer Medicine Information (CMI) leaflets.
Please select from one of the following Product Information:
- Diphereline® (triptorelin embonate)
- Dysport® (clostridium botulinum type A toxin-haemagglutinin complex)
- Somatuline® Autogel® (lanreotide acetate)
- To learn more about Somatuline® Autogel® click here https://somatuline.com.au (for Australian Healthcare Professionals* only)
- Somatuline® LA® (lanreotide acetate)
- NutropinAq® (somatropin)
- Cabometyx® (cabozantinib)
- To learn more about Cabometyx click here cabometyx.com.au (for Australian Healthcare Professionals* only)
Stay Informed
Please enter details below to receive important product and company updates from Ipsen
*A person who is registered as a health practitioner in Australia and who in the course of their professional activities may prescribe, dispense, recommend, supply or administer a prescription medicine